Brief: Bioretec Submits De Novo Request For Market Authorization In U.S.
05/05/2022 07:10
May 5 (Reuters) - Bioretec Oy BRETEC.HE :
* HAS SUBMITTED A DE NOVO REQUEST FOR MARKET AUTHORIZATION
IN
UNITED STATES FOR REMEOS™ TRAUMA SCREW BASED ON BIORESORBABLE
MAGNESIUM ALLOY
* ESTIMATES MARKET AUTHORIZATION IN UNITED STATES TO BE
GRANTED
DURING SECOND HALF OF 2022
Source text for Eikon: ID:nWkr6Fsr7z
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million